Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer
Clinical trial NCT06196658 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06196658
- Sponsor
- Zhang Xiaofeng,MD
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2026-12-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.